Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer.

Authors

• Chellappagounder Thangavel
• Ettickan Boopathi
• Yi Liu
• Christopher McNair
• Alex Haber
• Maryna Perepelyuk
• Anshul Bhardwaj
• Sankar Addya
• Adam Ertel
• Sunday Shoyele
• Ruth Birbe
• Joseph M Salvino
• Adam P Dicker
• Karen E Knudsen
• Robert B Den

Publication/Presentation Date

3-15-2018

Volume

24

Issue

6

First Page

1402

Last Page

1414

ISSN

1557-3265

Published In/Presented At

Thangavel, C., Boopathi, E., Liu, Y., McNair, C., Haber, A., Perepelyuk, M., Bhardwaj, A., Addya, S., Ertel, A., Shoyele, S., Birbe, R., Salvino, J. M., Dicker, A. P., Knudsen, K. E., & Den, R. B. (2018). Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 24(6), 1402–1414. https://doi.org/10.1158/1078-0432.CCR-17-2074

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

29311118

Department(s)

Administration and Leadership

Document Type

Article